International study clarifies role of hydrocortisone in the management of patients
The meta-analysis, involving almost 8,000 participants was a collaboration between the Raymond Poincaré AP-HP Hospital, Versailles SQY University, Paris-Saclay University and Inserm, in conjunction with The George Institute for Global Health in Sydney, Australia and the University of California, San Francisco, USA.
Tens of thousands of lives a year could be saved by new treatment protocol for brain
The George Institute for Global Health today announced data from the phase III INTERACT3 study demonstrating that a new combination of treatments for stroke due to intracerebral haemorrhage (ICH) significantly improves the chances combination of treatments in patients with this serious condition.
New study shows common blood pressure meds under-used for migraine
The first known large-scale review of international studies on the positive effect of blood pressure (BP) medicines across all classes in preventing migraine shows these common drugs could be used much more widely, at low cost, than is the case with current practice, according to a new paper published
Study shows ultra-low-dose 4-in-1 blood pressure pill would be cost-effective in Australia
Treating high blood pressure with a ‘quadpill’ tablet containing very low doses of four commonly used, low-cost medicines is not only more effective than usual care but is also comparably cost-effective, according to a new analysis by researchers at The George Institute for Global Health.1
Recent Posts
-
International study clarifies role of hydrocortisone in the management of patients
-
Tens of thousands of lives a year could be saved by new treatment protocol for brain
-
New study shows common blood pressure meds under-used for migraine
-
Study shows ultra-low-dose 4-in-1 blood pressure pill would be cost-effective in Australia